XM tidak memberikan layanan kepada penduduk Amerika Serikat.
R
R

Resmed


Berita

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change West Pharmaceutical Services Inc WST.N +4.9% Dollar Tree Inc DLTR.OQ +3.3% Bio Rad Laboratories Inc BIO.N +3.2% Bath & Body Works Inc BBWI.N +3.2% General Motors Co GM.N +3.2% Bottom Performers Percent Change Resmed Inc RMD.N -4.8% Ave
D
D
T
U
A
R

U.S. STOCKS United States Steel, Ambac Financial, Apple

BUZZ-U.S. STOCKS ON THE MOVE-United States Steel, Ambac Financial, Apple Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes slipped in volatile trading on Wednesday ahead of the Federal Reserve's highly anticipated first interest rate cut in more than four years, with jitters over the magnitude of the reduction dominating mood.
A
B
C
G
M
N
S
U
U
U
R

U.S. STOCKS Powerfleet, NMI, Vivos Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Powerfleet, NMI, Vivos Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were flat on Wednesday as investors stepped onto the sidelines ahead of the Federal Reserve's highly anticipated first interest rate cut in more than four years, with bets favoring a 50-basis-point reduction.
B
G
M
N
U
C
U
U
R

ResMed falls as Wolfe Research downgrades to 'underperform' on 1 risks

BUZZ-ResMed falls as Wolfe Research downgrades to 'underperform' on GLP-1 risks ** Shares of medical device maker ResMed RMD.N fall 6.1% to $235.65 ** Brokerage Wolfe Research downgrades to "underperform" from "peer perform", sets PT of $180 * Expect significant risk of disruption in patient demand next year as FDA likely to approve Eli Lilly's LLY
U
R

KeyBanc says sleep apnea device makers to benefit from new Apple Watch feature

BUZZ-KeyBanc says sleep apnea device makers to benefit from new Apple Watch feature ** Brokerage KeyBanc Capital Markets says it views the news of Apple AAPL.O launching sleep apnea detection in its new Watch Series 10, and existing Watch Series 9 and Watch Ultra 2 as positive for medical device makers Resmed RMD.N and Inspire Medical Systems INSP.
A
G
R

U.S. STOCKS Lumen Technologies, Insulet, PDD Holdings

BUZZ-U.S. STOCKS ON THE MOVE-Lumen Technologies, Insulet, PDD Holdings Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 rose on Tuesday in mixed trading ahead of a highly anticipated quarterly report from Nvidia and economic data expected later in the week.
N
W
U
U
C
M
R

U.S. STOCKS Eli Lilly, JD.com, Super Micro Computer

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, JD.com, Super Micro Computer Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were lower on Tuesday, weighed down by tech-related stocks, as caution prevailed ahead of a highly anticipated earnings report from Nvidia and crucial economic data expected later in the week.
N
U
U
C
M
R

Resmed Expands Board By Appointing Christopher Delorefice

BRIEF-Resmed Expands Board By Appointing Christopher Delorefice Aug 15 (Reuters) - Resmed Inc RMD.N : RESMED EXPANDS ITS BOARD OF DIRECTORS AND APPOINTS HEALTHCARE EXECUTIVE AND SEASONED FINANCE LEADER CHRISTOPHER DELOREFICE TO ITS BOARD Source text for Eikon: ID:nGNX7KRqxN Further company coverage: RMD.N
R

Australia shares slump more than 3% as US recession worries trigger sell-off

Australia shares slump more than 3% as US recession worries trigger sell-off ASX 200 posts worst session since June 2022 ASX volatility index at more than 2-year high Tech stocks lose 6.6%, financials drop 5% RBA policy decision due on Tuesday Updates to close By Himanshi Akhand and Rajasik Mukherjee Aug 5 (Reuters) - Australian shares slumped more than 3% in their worst trading session in over two years on Monday, joining a global sell-off in riskier assets after weak U.S.
A
R

Australia-listed shares of ResMed climb to 1-year high as analysts hike PT

BUZZ-Australia-listed shares of ResMed climb to 1-year high as analysts hike PT ** ASX-listed shares of ResMed RMD.AX RMD.N rise as much as 7% to A$34.020, their highest since Aug 2, 2023 ** Analysts at J.P. Morgan lift their price target on the medical equipment maker to A$37 from A$34.5 after its quarterly results ** Macquarie analysts raise PT to A$36.25 from A$35.40 ** U.S.-based co on Friday reported adj.
R

Resmed Inc reports results for the quarter ended in January - Earnings Summary

Resmed Inc reports results for the quarter ended in January - Earnings Summary Resmed Inc RMD.N reported quarterly adjusted earnings of $2.08​​ per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of $1.60. The mean expectation of twelve analysts for the quarter was for earnings of $2.07 per share.
R

Resmed Inc reports results for the quarter ended in June - Earnings Summary

Resmed Inc reports results for the quarter ended in June - Earnings Summary Resmed Inc RMD.N reported quarterly adjusted earnings of $2.08​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $1.60. The mean expectation of twelve analysts for the quarter was for earnings of $2.07 per share.
R

ResMed meets estimates on steady demand for its sleep apnea devices

ResMed meets estimates on steady demand for its sleep apnea devices Aug 1 (Reuters) - Medical equipment maker ResMed RMD.N reported fourth-quarter revenue in line with estimates on Thursday, on steady demand for its sleep apnea treatment devices. The company's quarterly revenue rose 9% to $1.22 billion, in line with estimates of $1.22 billion. ResMed makes ventilators and machines that provide continuous and bilateral positive airway pressure, known as CPAP and BIPAP, which are used for non-inva
R

Resmed Q4 Adjusted EPS USD 2.08 Vs. IBES Estimate USD 2.07

BRIEF-Resmed Q4 Adjusted EPS USD 2.08 Vs. IBES Estimate USD 2.07 Aug 01 (Reuters) - Resmed Q4 EPS USD 1.98. Q4 revenue USD 1,200 million vs. IBES estimate USD 1,217 million Q4 adjusted gross margin 59.1% Q4 gross margin 58.5%
R

Resmed Inc <RMD.N> expected to post earnings of $2.07 a share - Earnings Preview

Resmed Inc expected to post earnings of $2.07 a share - Earnings Preview Resmed Inc RMD.N , RMD is expected to show a rise in quarterly revenue when it reports results on August 1 for the period ending June 30 2024 The San Diego California-based company is expected to report a 8.4% increase in revenue to $1.217 billion from $1.12 billion a year ago, according to the mean estimate from 13 analysts, based on LSEG data.
R

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change ON Semiconductor Corp ON.OQ +12.2% Revvity Inc RVTY.N +8.7% Resmed Inc RMD.N +5.5% Tesla Inc TSLA.OQ +4.9% McDonald's Corp MCD.N +4.2% Bottom Performers Percent Change Enphase Energy Inc ENPH.OQ -5.2% Southwest Airlines Co LUV.N -3.3%
T
O
U
E
G
R

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change ON Semiconductor Corp ON.OQ +13.3% Dexcom Inc DXCM.OQ +6.2% Revvity Inc RVTY.N +5.5% Resmed Inc RMD.N +4.7% Tesla Inc TSLA.OQ +4.6% Bottom Performers Percent Change Constellation Brands Inc STZ.N -3.0% Franklin Resources Inc BEN.N -2.7
T
W
O
U
D
R

U.S. STOCKS Hartford Financial, Avantor, WesBanco

BUZZ-U.S. STOCKS ON THE MOVE-Hartford Financial, Avantor, WesBanco Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street bounced back on Friday with the blue-chip Dow leading the charge as some megacap tech and chip stocks recovered from the week's pummeling, while a largely in-line key inflation reading kept bets of an early rate cut alive.
B
B
C
G
N
U
U
A
M
R

Australia, New Zealand corporate earnings week ahead

DIARY-Australia, New Zealand corporate earnings week ahead July 26 (Reuters) - Diary of Australia and New Zealand (.AXJO, .NZ50) corporate earnings for the week ahead AUSTRALIA & NEW ZEALAND EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 29-Jul-2024 BMO CCP.AX Credit Corp Group Ltd Full Year 2024 Credit Corp Group Ltd Earnings Release 30-Jul-2024 22:30 RIO.L RIO.AX Rio Tinto PLC Rio Tinto Ltd Half Year 2024 Rio Tinto PLC Earnings Release 30-Jul-2024 NTS CIA.AX Champion Iron Ltd
A
R
R

U.S. STOCKS Constellation Brands, First Foundation, Repay Holdings

BUZZ-U.S. STOCKS ON THE MOVE-Constellation Brands, First Foundation, Repay Holdings Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was set to open slightly lower on Wednesday ahead of a holiday-shortened trading session, as investors assessed jobs data while being on the lookout for more economic reports and the Federal Reserve's June policy meeting minutes.
T
U
R
R



Kondisi

Aset Populer

Pengungkapan: Entitas XM Group menyediakan layanan khusus eksekusi dan akses ke Fasilitas Trading Online kami, yang memungkinkan Anda untuk melihat dan/atau menggunakan konten yang tersedia pada atau melalui situs, yang tidak untuk mengubah atau memperluas, serta tidak mengubah atau memperluas hal tersebut. Akses dan penggunaan ini selalu sesuai dengan: (i) Syarat dan Ketentuan; (ii) Peringatan Risiko; dan (iii) Pengungkapan Penuh. Oleh karena itu, konten disediakan hanya sebagai informasi umum. Anda juga harus ketahui bahwa konten Fasilitas Trading Online kami bukan sebagai ajakan atau tawaran untuk untuk melakukan transaksi apa pun di pasar finansial. Trading di pasar finansial mana pun melibatkan tingkat risiko yang signifikan pada modal Anda.

Semua materi yang diterbitkan di Fasilitas Trading Online kami hanya untuk tujuan edukasi/informasi dan tidak boleh mengandung nasihat dan rekomendasi finansial, pajak investasi atau trading, catatan harga trading kami, penawaran, permintaan, transaksi dalam instrumen finansial apa pun atau promo finansial untuk Anda yang tidak diminta.

Konten pihak ketiga apa pun, serta konten yang disiapkan oleh XM, seperti opini, berita, riset, analisis, harga, informasi lain atau link ke situs pihak ketiga yang tersedia "sebagaimana adanya", sebagai komentar pasar umum dan bukan menjadi nasihat investasi. Sejauh konten apa pun ditafsirkan sebagai penelitian investasi, Anda harus memperhatikan dan menerima bahwa konten tersebut tidak dimaksudkan dan belum disiapkan sesuai dengan persyaratan hukum yang dirancang untuk mempromosikan kemandirian riset investasi dan dengan demikian akan dianggap sebagai komunikasi pemasaran di bawah hukum dan peraturan yang relevan. Mohon dipastikan bahwa Anda telah membaca dan memahami Notifikasi pada Riset Investasi Non-Independen dan Peringatan Risiko kami mengenai informasi di atas, yang dapat diakses disini.

Peringatan Resiko: Modal Anda beresiko. Produk dengan leverage mungkin tidak cocok bagi semua orang. Silahkan pertimbangkan Pengungkapan Resiko kami.